Correlation Between Novo Integrated and Oncology Institute

Can any of the company-specific risk be diversified away by investing in both Novo Integrated and Oncology Institute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Integrated and Oncology Institute into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novo Integrated Sciences and Oncology Institute, you can compare the effects of market volatilities on Novo Integrated and Oncology Institute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Integrated with a short position of Oncology Institute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Integrated and Oncology Institute.

Diversification Opportunities for Novo Integrated and Oncology Institute

0.76

Correlation Coefficient

Novo Integrated  Oncology Institute

Poor diversification

The 3 months correlation between Novo and Oncology is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Novo Integrated Sciences and Oncology Institute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncology Institute and Novo Integrated is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Integrated Sciences are associated (or correlated) with Oncology Institute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncology Institute has no effect on the direction of Novo Integrated i.e., Novo Integrated and Oncology Institute go up and down completely randomly.

Pair Corralation between Novo Integrated and Oncology Institute

Given the investment horizon of 90 days Novo Integrated Sciences is expected to generate 1.79 times more return on investment than Oncology Institute. However, Novo Integrated is 1.79 times more volatile than Oncology Institute. It trades about 0.0 of its potential returns per unit of risk. Oncology Institute is currently generating about -0.01 per unit of risk. If you would invest  218.00  in Novo Integrated Sciences on September 2, 2024 and sell it today you would lose (213.59) from holding Novo Integrated Sciences or give up 97.98% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	97.58%
Values	Daily Returns

Novo Integrated Sciences  vs.  Oncology Institute

Novo Integrated Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novo Integrated Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Oncology Institute

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncology Institute has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Novo Integrated and Oncology Institute

The main advantage of trading using opposite Novo Integrated and Oncology Institute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Integrated position performs unexpectedly, Oncology Institute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncology Institute will offset losses from the drop in Oncology Institute's long position.

The idea behind Novo Integrated Sciences and Oncology Institute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.